TOP 100 WEIGHT LOSS SITES
| |||
|
| |||
| |||
|
| |||
| 1st World Congress On Interventional Therapies For Type 2 Diabetes: Session Highlights Nearly 100 of the world's leading authorities on diabetes, health care policy and finance from public and private sectors will gather in New York City next week to discuss the appropriate role of new interventional therapies for the treatment of Type 2 Diabetes. Currently, the condition is one of the fastest-growing epidemics in the world, affecting an estimated 23.6 million people in the United States in 2007 alone, and is one of the costliest conditions to treat. medicalnewstoday.com |
True, False Or Unproven? Medical Myths For The Holiday Season In a study published in the Christmas 2008 issue of the British Medical Journal, Aaron Carroll, M.D., M.S., and Rachel Vreeman, M.D., M.S., of the Indiana University School of Medicine, explore the science behind six myths commonly associated with the holidays yet relevant year-round. Sugar makes kids hyperactive. Suicides increase over the holidays. Poinsettias are toxic. medicalnewstoday.com |
General Healthcare Group Sees Weight Loss Procedures Rise By Over 30 Percent, UK General Healthcare Group (GHG), the leading provider of independent health care services in the UK, has reported that the number of patients undergoing weight loss surgery at its BMI Healthcare hospitals increased by more than 30 percent in October 2008 through February 2009 compared to the same period in the previous financial year. medicalnewstoday.com |
Study Indicates Support Group Attendance Improves Post-Surgical Weight Loss Major scientific contributors within the bariatric and psychiatric industries publicized the results of a recent study demonstrating that LAP-BAND(R) patients who regularly attend support groups experience considerably higher rates of post-surgical weight loss. Authors Dr. Kathryn A. Kaiser, Dr. Susan Franks and Dr. Adam Smith discussed their findings at the 26th Annual American Society for Metabolic & Bariatric Surgery (ASMBS) Meeting. medicalnewstoday.com |
Sirona Biochem Says New Obesity Data Shows It's On The Right Path Sirona Biochem Corp. (TSX-V: SBM), an emerging biotech company focused on diabetes and obesity, says a newly released Dutch diabetes research paper claims obesity alone may be the best predictor of undiagnosed diabetes. Sirona Biochem CEO, Dr. Howard Verrico, said, "This study by Radboud University Nijmegen Medical Centre found undiagnosed in 101 high-risk patients out of 3,724 who took part, but only two were diagnosed out of a random sample of 465 low-risk patients. medicalnewstoday.com |